pegaspargase
Pronunciation: peg-AS-par-gase
Other Name(s): Oncaspar®
Appearance: Clear solution
for injection; may be mixed into larger bags of fluids
Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.
Drug Monograph
Aug 2022
Eligibility Forms
Pegaspargase - Relapsed or Refractory Pediatric ALL Lymphoblastic Lymphoma or Mixed_Biphenotypic Leukemia Pegaspargase - Newly Diagnosed Pediatric ALL Lymphoblastic Lymphoma or Mixed_Biphenotypic Leukemia Pegaspargase - Extranodal Natural Killer T-cell Lymphoma Pegaspargase (Inpatient) - Adult Acute Lymphoblastic Leukemia (ALL) Lymphoblastic Lymphoma Mixed or Biphenotypic Leukemia Pegaspargase (Outpatient) - Adult Acute Lymphoblastic Leukemia (ALL) Lymphoblastic Lymphoma Mixed or Biphenotypic LeukemiaPatient Info Sheet
Dec 2022
What it is used for
- Used in combination with other cancer drugs for treating certain types of blood cancers (such as Acute Lymphoblastic Leukemia) or lymphomas.